Lola Fashoyin-Aje
Medical Oncologist / Deputy Division Director in the Division of Oncology at Food and Drug Administration (FDA) at Harvard Medical School
Schools
- Harvard Medical School
Expertise
Links
Biography
Harvard Medical School
Lola A. Fashoyin-Aje, MD, MPH, is a medical oncologist and Deputy Division Director in the Division of Oncology 3 (DO3) in the Office of Oncologic Diseases (OOD) at the Food and Drug Administration (FDA). At the FDA, Dr. Fashoyin-Aje has served as clinical reviewer in the Gastrointestinal (GI) Malignancies team, and as team leader for the Breast Malignancies, Melanoma and Sarcoma, and Gastrointestinal Malignancies clinical teams. In her current role, she provides scientific and policy guidance and oversight to multidisciplinary teams reviewing drugs and biologics under development for the treatment of solid tumor (GI, sarcoma, melanoma) malignancies. She has also served as the Oncology Center of Excellence (OCE) Scientific Liaison for Cancer Disparities and in this role, has led the OCE’s efforts to improve inclusion of diverse demographic subgroups in clinical trials and participates in several internal and external scientific and policy working groups. Dr. Fashoyin-Aje also serves on the ASCO Health Equity Committee, the AACR Science of Cancer Health Disparities Scientific Program and Scientific Review committees, and the ASCO Cancer Research Committee. Prior to joining the FDA, Dr. Fashoyin-Aje completed her residency in internal medicine and fellowship in medical oncology at Johns Hopkins. She completed her undergraduate and graduate training at Columbia University and Yale University, respectively, and earned her medical degree from the University of Rochester.
Videos
Challenges in the approval of therapies for GI cancers
2018 NMQF Leadership Summit and Spring Health Braintrust: Policy & Advocacy Plenary
AC21 - Lola Fashoyin-Aje: Balancing Efficiency & Inclusivity to Develop Therapeutics that Work...
Improving diversity in clinical trial enrollment
FDA’s Lola Fashoyin-Aje: It's time to fix disparities in access to clinical trials
Lola Fashoyin-Aje
2020 Symposium: FDA Oncology Center of Excellence Initiatives to Advance Patient Engagement
Impact of COVID-19 on the regulatory approval process
Read about executive education
Other experts
Popular Courses
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Leading People and Teams
ESMT
Berlin, Germany
May 28
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
Looking for an expert?
Contact us and we'll find the best option for you.